when prevacid was first invented

HUNENBERG, Switzerland -- Alcon, Inc.(NYSE:ACL) reported global sales of $1,322. 7 million for the first quarter of 2007, an increase of 14. 3 percent compared to the first quarter of 2006, or 12. 0 percent excluding the impact of foreign exchange fluctuations. Net earnings for the first quarter of 2007 increased 17. 1 percent to $346. 2 million, or $1. 14 per share on a diluted basis, compared to $295. 7 million, or $0. 95 per share for the first quarter of 2006. Earnings in the first quarter of 2007 included a charge related to the impairment of certain assets of the company's refractive laser product line. The impact of this charge was $20. prevacid instructions prevacid soluble tablets prevacid verses nexium prevacid granules partial dose prevacid like medicines